Hutch News

Intermittent hormone therapy for prostate cancer inferior to continuous therapy

Intermittent hormone therapy for prostate cancer inferior to continuous therapy

Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
Hutch News - June 04, 2012
Lower income cancer patients less likely to join clinical trials

Lower income cancer patients less likely to join clinical trials

Joseph Unger-led study finds poor patients stymied by financial, logistical concerns, blocking representation and access to latest therapies
Hutch News - June 04, 2012